| Tocilizumab in patients with severe COVID-19: a retrospective cohort study G Guaraldi, M Meschiari, A Cozzi-Lepri, J Milic, R Tonelli, M Menozzi, ... The Lancet Rheumatology 2 (8), e474-e484, 2020 | 1035 | 2020 |
| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 258 | 2021 |
| Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ... The Journal of infectious diseases 211 (2), 178-186, 2015 | 219 | 2015 |
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 … A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ... Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015 | 143 | 2015 |
| Hypokalemia in patients with COVID-19 G Alfano, A Ferrari, F Fontana, R Perrone, G Mori, E Ascione, ... Clinical and experimental nephrology 25, 401-409, 2021 | 124 | 2021 |
| Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort A Mondi, A Cozzi‐Lepri, A Tavelli, S Rusconi, F Vichi, ... African Journal of Reproduction and Gynaecological Endoscopy 22 (1), 2019 | 66 | 2019 |
| Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—challenges, strengths, and opportunities in a global health emergency D Ferrari, J Milic, R Tonelli, F Ghinelli, M Meschiari, S Volpi, M Faltoni, ... PLoS One 15 (11), e0239172, 2020 | 61 | 2020 |
| Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort A Saracino, P Lorenzini, SL Caputo, E Girardi, F Castelli, P Bonfanti, ... Clinical Microbiology and Infection 22 (3), 288. e1-288. e8, 2016 | 45 | 2016 |
| Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 G Alfano, A Ferrari, F Fontana, G Mori, R Magistroni, M Meschiari, ... Clinical and experimental nephrology 25 (11), 1203-1214, 2021 | 44 | 2021 |
| Herpes simplex virus re-activation in patients with SARS-CoV-2 pneumonia: a prospective, observational study E Franceschini, A Cozzi-Lepri, A Santoro, E Bacca, G Lancellotti, ... Microorganisms 9 (9), 1896, 2021 | 38 | 2021 |
| Antiretroviral drugs and risk of chronic alanine aminotransferase elevation in human immunodeficiency virus (HIV)-monoinfected persons: the data collection on adverse events of … H Kovari, CA Sabin, B Ledergerber, L Ryom, P Reiss, M Law, C Pradier, ... Open forum infectious diseases 3 (1), ofw009, 2016 | 34 | 2016 |
| COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion C Vacchi, M Meschiari, J Milic, M Marietta, R Tonelli, G Alfano, S Volpi, ... Rheumatology 59 (12), e147-e150, 2020 | 31 | 2020 |
| Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature N Riva, I Franconi, M Meschiari, E Franceschini, C Puzzolante, G Cuomo, ... Infection 45, 385-388, 2017 | 30 | 2017 |
| Clinical and microbiological characteristics of visceral leishmaniasis outbreak in a Northern Italian nonendemic area: a retrospective observational study E Franceschini, C Puzzolante, M Menozzi, L Rossi, A Bedini, G Orlando, ... BioMed Research International 2016, 2016 | 28 | 2016 |
| Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020; 2 (8): e474–84 G Guaraldi, M Meschiari, A Cozzi-Lepri, J Milic, R Tonelli, M Menozzi, ... Epub 2020/08/25. https://doi. org/10.1016/S2665-9913 (20) 30173-9 PMID: 32835257, 0 | 28 | |
| Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020; 2: e474–84 G Guaraldi, M Meschiari, A Cozzi-Lepri, J Milic, R Tonelli, M Menozzi, ... | 28 | |
| Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients G Alfano, A Ferrari, F Fontana, G Mori, G Ligabue, S Giovanella, ... Kidney Research and Clinical Practice 40 (2), 231, 2021 | 27 | 2021 |
| Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting A d’Arminio Monforte, A Cozzi-Lepri, A Di Biagio, G Marchetti, ... Journal of Antimicrobial Chemotherapy 74 (5), 1363-1367, 2019 | 27 | 2019 |
| Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator C Mussini, A Cozzi-Lepri, M Menozzi, M Meschiari, E Franceschini, ... Clinical Microbiology and Infection 27 (8), 1137-1144, 2021 | 25 | 2021 |
| Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol 2: e474–e484 G Guaraldi, M Meschiari, A Cozzi-Lepri, J Milic, R Tonelli, M Menozzi, ... | 25 | 2020 |
